Jianyong Li

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma

Jie Xu, Lijuan Chen, Shuangshuang Yang et al. · Proceedings of the National Academy of Sciences · 2019 · 407 citations · Full text

Medicine, Hematology, Immunology +17

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Zijun Y. Xu‐Monette, Lin Wu, Carlo Visco et al. · Blood · 2012 · 391 citations · Full text

Medicine, Hematology, Oncology +14

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value

Wen‐Lian Chen, Jinghan Wang, Aihua Zhao et al. · Blood · 2014 · 307 citations · Full text

Medicine, Hematology, Oncology +16

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Constantine S. Tam, Jennifer R. Brown, Brad S. Kahl et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacology +8